临床儿科杂志 ›› 2026, Vol. 44 ›› Issue (5): 381-393.doi: 10.12372/jcp.2026.25e1596

• 标准·方案·指南 •    下一篇

儿童特应性皮炎非药物干预管理专家共识

中国妇幼保健协会儿童变态反应专业委员会 中华医学会儿科学分会皮肤性病学组 《临床儿科杂志》编辑委员会   

  • 收稿日期:2025-12-16 录用日期:2026-04-02 出版日期:2026-05-15 发布日期:2026-05-08
  • 通讯作者: 李明,电子信箱:mingli@fudan.edu.cn; 任韵清,电子信箱:yqren@zju.edu.cn
  • 基金资助:
    浙江省“尖兵”“领雁”研发攻关计划项目(2025C02080)

Expert consensus on non-pharmacological interventions for atopic dermatitis in children

Professional Committee of Child Allergology, China Maternal and Child Health Association; Dermatology and Venereology Group of Pediatric Branch Society, Chinese Medical Association: Editorial Board of the Journal of Clinical Pediatrics   

  • Received:2025-12-16 Accepted:2026-04-02 Published:2026-05-15 Online:2026-05-08

摘要:

特应性皮炎(AD)作为一种慢性、复发性的炎症性皮肤病,自21世纪以来,其在中国及国际范围内的发病率呈持续上升态势,已成为重要的公共卫生议题。AD的综合管理体系主要涵盖药物治疗与非药物干预两大核心内容。尽管近年来AD的药物治疗方法不断丰富,但鉴于AD发病机制的高度复杂性以及显著的临床异质性,单纯依靠药物干预难以实现AD的最佳控制,非药物干预始终是AD防治的关键基础。目前,国内外已发表的AD治疗共识及指南中,干预策略多以药物治疗为核心架构,对非药物干预的系统性关注与整合明显欠缺。基于此背景,中国妇幼保健协会儿童变态反应专业委员会、中华医学会儿科学分会皮肤性病学组和《临床儿科杂志》编辑委员会,组织了来自30家医疗单位的33位皮肤科专家,依据当前国内外最新研究进展及临床实践经验,制定本项共识。本共识系统地阐述了AD的非药物干预管理策略,核心建议包括规避诱发因素、规范皮肤护理以维持皮肤屏障的稳定状态、落实健康教育与心理支持;强调了非药物干预作为AD管理基础措施的重要意义,旨在降低AD的复发率并提升患儿的生活质量;同时明确了各项措施的适用场景与实施要点,为临床工作者、患儿家属及健康管理人员提供了系统且实用的指导。

关键词: 特应性皮炎, 非药物干预, 皮肤护理, 皮肤屏障稳态, 儿童

Abstract:

Atopic dermatitis (AD), a chronic and recurrent inflammatory skin disorder, has witnessed a sustained global and domestic upward trend in incidence since the 21st century, emerging as a critical public health concern. The comprehensive management framework for AD encompasses two core pillars: pharmacotherapy and non-pharmacological interventions. Despite the expanding armamentarium of AD pharmacotherapies in recent years, the intricate pathogenesis and marked clinical heterogeneity of AD render monotherapy insufficient for optimal disease control. Non-pharmacological interventions thus remain an indispensable cornerstone in AD prevention and management. However, existing domestic and international AD treatment consensus and guidelines are predominantly structured around pharmacotherapy, with a notable paucity of systematic attention and integration of non-pharmacological strategies. Against this backdrop, the Children’s Allergy Committee of the China Maternal and Child Health Association, the Dermatology and Venereology Group of Pediatric Branch Society, Chinese Mechical Association and Editorial Board of the Journal of Clinical Pediatrics convened 33 dermatology experts from 30 medical institutions to formulate this consensus, drawing on the latest domestic and international research advances and clinical practice experience. This consensus systematically delineates non-pharmacological management strategies for AD, with core recommendations including avoidance of triggering factors, standardized skin care to maintain skin barrier homeostasis, and implementation of health education and psychological support. It emphasizes the pivotal role of non-pharmacological interventions as foundational measures in AD management, aiming to reduce disease recurrence and enhance the quality of life of affected children. Additionally, it clarifies the applicable scenarios and key implementation points for each measure, providing systematic and practical guidance for clinicians, caregivers of affected children, and health managers.

Key words: atopic dermatitis, non-pharmacological intervention, skin care, skin barrier homeostasis, child

中图分类号: 

  • R72